|We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.|
The March 2014 ebola outbreak is the largest on record. As of July 2014, over 1,200 cases have been confirmed and over 600 dead in Guinea, Liberia and Sierra Leone. The first reported case in Nigeria occurred in late July as a passenger died of ebola within a few days of landing and there is fear that he exposed fellow passengers on several legs of his plane trip to Nigeria. It is only a matter of time until this spreads to Europe and the US. This site will be used to post news, updates and investments related to the ebola outbreak.
As of now, there are 2 public companies that have a strong emphasis in the ebola arena:
Corgenix Medical Corp - CONX traded in the US. They are a small medical company in Colorado, they are profitable, have no debt and are working on the only rapid diagnostic ebola test. They were recently awarded a $2.9 million grant from the NIH in June to accelerate development. As of the end of July 2014, their market cap is a tiny $20 million. Their website is corgenix.com.
Tekmira Pharmaceutical Corp - TKM traded in Canada, TKMR in the US. They are in Phase I development of finding a cure for ebola. Their website is: tekmira.com.
In addition, there are a few other companies involved in ebola testing and research work:
SRPT - SAREPTA THERAPEUTICS DE - sareptatherapeutics.com
:BCRX - BIOCRYST PHARMACEUTICALS INC - biocryst.com
|© 2020 Knight Sac Media. Data provided by IEX, Alpha Vantage, Coinbase, Binance, Fintel and CityFALCON News|